TVSCN > Networks > Cardiovascular, Stroke, Renal and Diabetes > Cardiovascular disease & stroke

Cardiovascular disease & stroke

Cardiovascular disease places a major burden on individuals and society. It accounts for almost a quarter of all premature deaths and is a key driver of health inequalities, accounting for a quarter of the life expectancy gap between rich and poor. CVD is also largely preventable. Primary prevention through population measures and modification of lifestyle risk factors is essential and will have the greatest long-term benefit. However, there is also substantial benefit to be gained by improving detection and management of the high-risk conditions for CVD. Treatment of these conditions is highly effective at preventing heart attack, stroke and dementia.

The NHS Long Term Plan has identified CVD prevention as a national clinical priority, with the potential to prevent 150,000 strokes, heart attacks and cases of dementia over the next ten years by improving the detection and management of high blood pressure, high cholesterol and atrial fibrillation.

Strategic Clinical Networks (SCNs) provide an organisational model through which multiple professionals, clinicians, organisations and patients/carers and their representatives will come together to improve patient outcomes and benefit population health across a range of boundaries.

The Thames Valley (TV) SCNs are currently working on a programme of work to support CCG leads and primary care networks to deliver improvements by implementing the relevant NHS Long Term Plan commitments in a phased way.

Thames Valley aspirations to support achievement of the national ambitions for cardiovascular disease:

Atrial fibrillation
  • 90% of the expected number of people with atrial fibrillation (AF) to be detected by 2023, with a year-on-year increase within practices to reduce undiagnosed AF.
  • Every CCG to achieve 90% by 2023 for anticoagulation in patients with AF who are known to be at high risk of a stroke.
High blood pressure
  • 80% of the expected number of people with high blood pressure to be diagnosed by 2023, with a year-on-year increase within practices in hypertension diagnosis to reduce undiagnosed hypertension.
  • 80% of those diagnosed with high blood pressure to be treated to target as per NICE guidelines (below 140/90 mmHg for those under 80 years; below 150/90 mmHg for those aged 80 & over)
Addressing inequalities in the delivery of CVD interventions
  • To ensure 85% of all the practices within each CCG to meet the expected hypertension and AF prevalence and treatment objective.

Key contacts for the CVD/Stroke Thames Valley Strategic Clinical Networks

CVD SCN LTC/CVD Clinical Lead, Dr. Raj Thakkar

CVD SCN Stroke Clinical Lead, Dr. Matthew Burn

Senior Clinical Network Manager, Julia Coles

Business Support Officer, Nqobile Tsabedze